戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 receptor NOD2 is a genetic cause of uveitis (Blau syndrome).
2 atory disorders, including Crohn disease and Blau syndrome.
3 rapies for Nod2-associated disorders such as Blau syndrome.
4 diate the inflammation seen in patients with Blau syndrome.
5 cause a granulomatous type of uveitis called Blau syndrome.
6 atous disorders, such as Crohn's disease and Blau syndrome.
7 c inflammatory bowel disorder, and can cause Blau syndrome.
8 d with susceptibility to Crohn's disease and Blau syndrome.
9 ay phenotypic traits beyond those of classic Blau syndrome.
10 up results in a 5-year longitudinal study of Blau syndrome.
11 rohn's disease and rare mutations that cause Blau syndrome.
12     Human macrophages from two patients with Blau syndrome also showed a reduction of both cytokine p
13 cific mutations in the human NOD2 gene cause Blau syndrome, an autosomal dominant form of uveitis, ar
14 ion domain-containing protein 2 (NOD2) cause Blau syndrome, an inflammatory disorder characterized by
15 meostasis and disease, with implications for Blau syndrome and Crohn's disease.
16 RD15 is an important susceptibility gene for Blau syndrome and for other familial granulomatoses that
17                                              Blau syndrome and its sporadic counterpart, early-onset
18 fic types of syndromic uveitis-such as NOD2 (Blau syndrome) and CAPN5 NIV (neovascular inflammatory v
19 e is responsible for the Mendelian disorder, Blau syndrome, and also predisposes to Crohn disease.
20 two inflammatory diseases, Crohn disease and Blau syndrome, and are thought to contribute to disease
21 ted with the development of Crohn's disease, Blau syndrome, and gastrointestinal cancers.
22                                              Blau syndrome (BS) and Crohn disease (CD) are both chara
23 duction in cells obtained from subjects with Blau syndrome compared with healthy control subjects.
24 tion were also observed in several unrelated Blau syndrome families, some of whose phenotypes include
25                             The phenotype of Blau syndrome has proven to be more complex than initial
26 ined the effect of mutations associated with Blau syndrome in vitro, but none has looked at the impli
27         Furthermore, we presented 2 cases of Blau syndrome in which recombinant human IL-1 receptor a
28 ear cells cultured in vitro, obtained from 5 Blau syndrome individuals with a NOD2 (CARD15) mutation.
29                                              Blau syndrome is a monogenic disease resulting from muta
30                                              Blau syndrome is a rare, autosomal-dominant, autoinflamm
31                                              Blau syndrome is an autoinflammatory disease resulting f
32 ependent autoinflammatory cryopyrinopathies, Blau syndrome is not mediated by excess IL-1beta or othe
33 omerization domain containing 2 (NOD2) cause Blau syndrome is unknown.
34    Affected family members from the original Blau syndrome kindred were heterozygous for the R334W mi
35                                              Blau syndrome (MIM 186580), first described in a large,
36       Interestingly, CD4(+) T cells from two Blau syndrome patients show elevated IL-17 and increased
37               The granulomatous character of Blau syndrome provides an opportunity to look at possibl
38 se carrying the most common mutation seen in Blau syndrome, R314Q (corresponding to R334Q in humans).
39 both R314Q mice and cells from patients with Blau syndrome show reduced responses to MDP.
40 s analyzed as a positional candidate for the Blau syndrome susceptibility gene, by direct DNA sequenc
41 tion of IFN-gamma may occur in patients with Blau syndrome, thereby contributing to the granulomatous
42  feature historically considered absent from Blau syndrome, while typical of the adult form of sarcoi
43 t of a CARD15 mutation-positive patient with Blau syndrome who exhibited interstitial lung disease, a